-
EP3543701
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3543701
| EP3543701 - BIOMARKER, METHOD FOR SEARCHING DISEASE-RELATED GENE, AND RENAL CANCER MARKER [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 28.01.2022 Database last updated on 18.11.2024 | |
| Former | Examination is in progress Status updated on 14.05.2021 | ||
| Former | Request for examination was made Status updated on 23.08.2019 | ||
| Former | The international publication has been made Status updated on 05.05.2018 | Most recent event Tooltip | 28.01.2022 | Application deemed to be withdrawn | published on 02.03.2022 [2022/09] | Applicant(s) | For all designated states Japanese Foundation For Cancer Research 3-8-31, Ariake Koto-ku Tokyo 135-8550 / JP | For all designated states Osaka University 1-1 Yamadaoka Suita-shi, Osaka 565-0871 / JP | [2019/39] | Inventor(s) | 01 /
UEDA, Koji c/o JAPANESE FOUNDATION FOR CANCER RESEARCH 8-31 Ariake 3-chome Koto-ku Tokyo 135-8550 / JP | 02 /
OHNISHI, Naomi c/o JAPANESE FOUNDATION FOR CANCER RESEARCH 8-31 Ariake 3-chome Koto-ku Tokyo 135-8550 / JP | 03 /
NONOMURA, Norio c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | 04 /
UEMURA, Motohide c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | 05 /
FUJITA, Kazutoshi c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | 06 /
TSUJIKAWA, Kazutake c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | 07 /
JINGUSHI, Kentarou c/o OSAKA UNIVERSITY 1-1 Yamadaoka Suita-shi Osaka 565-0871 / JP | [2019/39] | Representative(s) | Schön, Christoph Dr. Schön, Neymeyr & Partner mbB Bavariaring 26 80336 München / DE | [2019/39] | Application number, filing date | 17864046.2 | 26.10.2017 | [2019/39] | WO2017JP38812 | Priority number, date | JP20160211239 | 28.10.2016 Original published format: JP 2016211239 | [2019/39] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018079689 | Date: | 03.05.2018 | Language: | JA | [2018/18] | Type: | A1 Application with search report | No.: | EP3543701 | Date: | 25.09.2019 | Language: | EN | [2019/39] | Search report(s) | International search report - published on: | JP | 03.05.2018 | (Supplementary) European search report - dispatched on: | EP | 26.06.2020 | Classification | IPC: | G01N33/68, C12Q1/68, G01N33/15, G01N33/50, G01N33/574, G01N33/92 | [2019/39] | CPC: |
C12Q1/6886 (EP,US);
G01N33/57438 (EP,US);
G01N33/50 (US);
G01N33/574 (US);
G01N33/57488 (EP,US);
G01N33/68 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/39] | Title | German: | BIOMARKER, VERFAHREN ZUM SUCHEN VON KRANKHEITSASSOZIIERTEM GEN UND NIERENKREBSMARKER | [2019/39] | English: | BIOMARKER, METHOD FOR SEARCHING DISEASE-RELATED GENE, AND RENAL CANCER MARKER | [2019/39] | French: | BIOMARQUEUR, PROCÉDÉ DE RECHERCHE D'UN GÈNE ASSOCIÉ À UNE MALADIE, ET MARQUEUR DU CANCER DU REIN | [2019/39] | Entry into regional phase | 20.05.2019 | Translation filed | 20.05.2019 | National basic fee paid | 20.05.2019 | Search fee paid | 20.05.2019 | Designation fee(s) paid | 20.05.2019 | Examination fee paid | Examination procedure | 26.04.2018 | Request for preliminary examination filed International Preliminary Examining Authority: JP | 20.05.2019 | Examination requested [2019/39] | 21.01.2021 | Amendment by applicant (claims and/or description) | 18.05.2021 | Despatch of a communication from the examining division (Time limit: M04) | 29.09.2021 | Application deemed to be withdrawn, date of legal effect [2022/09] | 15.10.2021 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2022/09] | Fees paid | Renewal fee | 20.05.2019 | Renewal fee patent year 03 | 30.10.2020 | Renewal fee patent year 04 | Penalty fee | Additional fee for renewal fee | 31.10.2021 | 05 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - F. RAIMONDO ET AL, "Differential protein profiling of renal cell carcinoma urinary exosomes", MOLECULAR BIOSYSTEMS, GB, (20130228), vol. 9, no. 6, doi:10.1039/c3mb25582d, ISSN 1742-206X, page 1220, XP055659684 [X] 1-6 * abstract * * page 1226; tables 2-3 * DOI: http://dx.doi.org/10.1039/c3mb25582d | [A] - TODD M. MORGAN ET AL, "NOVEL RENAL CELL CARCINOMA BIOMARKER IDENTIFICATION FROM URINARY EXOSOMES", JOURNAL OF UROLOGY., BALTIMORE, MD, US, (20120520), vol. 187, no. 4S, doi:10.1016/j.juro.2012.02.501, ISSN 0022-5347, XP055660146 [A] 1-6 * abstract * DOI: http://dx.doi.org/10.1016/j.juro.2012.02.501 | International search | [A]JP2012508577 (CARIS LIFE SCIENCES LUXEMBOURG HOLDINGS) [A] 1-5 * , paragraphs [0224], [0225], [0646] & WO 2010/056337 A2 paragraphs [00223], [00572], [00573] & US 2010/0113290 A1 & EP 2350320 A2 & CN 102301002 A *; | [A]JP2013544361 (KCI LICENSING, INC.) [A] 1-5 * , paragraph [0029] & WO 2012/071516 A2 paragraph [0031] & US 2012/0129186 A1 & US 2015/0346216 A1 & EP 2643693 A2 & CN 103097892 A *; | [A]EP2955232 (BORK PEER [DE]) [A] 1-5 * , examples (Family: none) *; | [A] - TAKAHASHI, ERI, "2P-11 Search of biomarker proteins in serum extracellular vesicle of renal and bladder cancer patients", Japan Proteome Society Convention Program and Abstracts. JPrOS 2016 Conference (JHUPO 14th Conference), (20160728), doi:10.14889/jhupo.2016.0.108.0, page 108, XP009518613 [A] 1-5 DOI: http://dx.doi.org/10.14889/jhupo.2016.0.108.0 | [A] - JINGUJI, KENTARO, "P-3192 Analysis of extracellular vesicles derived from clear cell type renal cell carcinoma tissue", The 74th Annual Meeting of the Japanese Cancer Association; October 8-10, 2015, (20150000), vol. 74, page P-3192, XP009519184 [A] 1-5 | [XY] - Ran Guo, "Proteins Secreted by Lung Adenocarcinoma Cells ― Identification of Candidate Diagnosis Markers from Culture Supernatants of Dissected Tumor Tissue ", JAPANESE JOURNAL OF LUNG CANCER, (20100101), vol. 50, no. 2, doi:10.2482/haigan.50.141, pages 141 - 150, XP009515257 [X] 1-3, 5 [Y] 4 DOI: http://dx.doi.org/10.2482/haigan.50.141 | [XY] - Guo Ran, "Proteome analysis for culture supernatant of primary pulmonary adenocarcinoma tumor tissue", The Journal of Tokyo Medical University, (20091030), vol. 67, no. 4, page 502, XP009504196 [X] 1-3, 5 [Y] 4 | [Y] - MORITA, TAKUYA, "Identification of exosome surface marker derived from Ewing sarcoma cell applicable to liquid biopsy", The Journal of Japanese Orthopaedic Surgical Society, (20150910), vol. 89, no. 8, pages 1796 2 - 7-22, XP009516050 [Y] 4 | [A] - KAWAKAMI, FURUO, "Proteomics of biomarker: Proteome statistic analysis using liquid chromatography/tandem mass spectrometry, and applications thereof", JSBSM Lett, (20100325), vol. 35, no. 1, ISSN 1881-5464, pages 4 - 12, XP009515258 [A] 1-5 | [A] - ZWICKL, H ET AL , "A novel technique to specifically analyze the secretome of cells and tissues", Electrophoresis, (20050701), vol. 26, no. 14, doi:10.1002/elps.200410387, ISSN 0173-0835, pages 2779 - 2785, XP055598872 [A] 1-5 * , abstracts, 1., 2. 1, 3. * DOI: http://dx.doi.org/10.1002/elps.200410387 | [A] - KIYOMI, ANNA, "Immunologic substance secreted from 3-dimensional human breast cancer, and effects on behavior of suppressor T cell thereof", Abstracts of The Pharmaceutical Society of Japan Annual Meeting, (20140000), vol. 134, page 30PMM-89, XP009515162 [A] 1-5 | [A] - BONIFATI, C ET AL, "IL -lalpha, IL -lbeta and psoriasis: conflicting results in the literature. Opposite behavior of the two cytokines in lessional or non-lessional extracts of whole skin", J Biol Regul Homeost Agents, (19970000), vol. 11, no. 4, ISSN 0393-974X, pages 133 - 136, XP009179746 [A] 1-5 * , MATERIALS AND METHODS * | [A] - KIYOHARA, YUMIKO, "Drug screening and grouping by sensitivity with a panel of primary cultured cancer spheroids derived from endometrial cancer", Cancer Science, (20160400), vol. 107, no. 4, doi:10.1111/cas.12898, ISSN 1347-9032, pages 452 - 460, XP055477668 [A] 1-5 * , abstract * DOI: http://dx.doi.org/10.1111/cas.12898 | [A] - BERGMAN A-C ET AL, "Identification of gel-separated tumor marker proteins by mass spectrometry", Electrophoresis , (20000201), vol. 21, no. 3, doi:10.1002/(SICI)1522-2683(20000201)21:3<679::AID-ELPS679>3.0.CO;2-A, ISSN 0173-0835, pages 679 - 686, XP000923086 [A] 1-5 * , Materials and Methods * DOI: http://dx.doi.org/10.1002/(SICI)1522-2683(20000201)21:3<679::AID-ELPS679>3.0.CO;2-A | [PX] - NAGAYAMA, SATOSHI, "Search for biomarkers for diagnosis of colorectal cancer by comprehensive analysis of resected tissue culture secretion exosome", Journal of Japan Surgical Society, (20170427), vol. 117, page 1, XP009518614 [PX] 1-5 | [PX] - S. Muraoka, R. Fujii, S. Nagayama, K. Ueda, "Proteome-wide profiling of viable colorectal cancer tissue-derived extracellular vesicle", Abstracts for Annual Meeting of Japanese Proteomics Society - JPrOS 2017 Conference (JHUPO 15th Conference), July 26-28 2017, (20170726), vol. 2017, doi:10.14889/jhupo.2017.0.148.0, page 148, XP009518018 [PX] 1-5 DOI: http://dx.doi.org/10.14889/jhupo.2017.0.148.0 | by applicant | JP2016086678 | JP2013140030 | WO2015005965 | - KAHLERT, C.KALLURI, R., J. Mol. Med., (20130000), vol. 91, no. 4, pages 431 - 437 | - AN, T. et al., J. Extracell. Vesicles, (20150000), vol. 4, page 27522 | - PEINADO, H. et al., Nat. Med., (20120000), vol. 18, no. 6, pages 883 - 891 | - COSTA-SLIVA, B. et al., Nat. Cell Biol., (20150000), vol. 17, no. 6, pages 816 - 826 | - HOSHINO, A. et al., Nature, (20150000), vol. 527, no. 7578, pages 329 - 335 | - LASSER, C. et al., J. Vis. Exp., (20120000), vol. 59, page e3037 | - GEISSLER, K. et al., Oncoimmunology, (20150000), vol. 4, page e985082 | - TELTSH, 0. et al., Oncotarget, (20150000), vol. 32, pages 33191 - 33205 | - GULDUR, M. E. et al., J. Pak. Med. Assoc., (20140000), vol. 3, pages 300 - 303 | - BUSSOLATI, B. et al., FASEB J., (20030000), vol. 17, no. 9, pages 1159 - 1161 | - WIKLANDER, O.P. et al., J. Extracell. Vesicles, (20150000), vol. 4, page 26316 | - TOMINAGA, N. et al., Adv. Drug Deliv. Rev., (20150000), vol. 95, pages 50 - 55 | - LAI, C. P. et al., ACS Nano., (20140000), vol. 8, no. 1, pages 483 - 494 | - GRUENWALD, V. et al., BMC Cancer, (20100000), vol. 10, page 695 | - VROLING, L. et al., Angiogenesis, (20090000), vol. 12, no. 1, pages 69 - 79 | - DEL PUERTO-NEVADO, L. et al., Br. J. Cancer, (20140000), vol. 110, pages 2700 - 2707 | - SHANKHAJIT, D. et al., International Journal of Nutrition, Pharmacology, Neurological diseases, (20120000), vol. 2, pages 3 - 7 |